HOME >> BIOLOGY >> NEWS
NIAID unveils bioterrorism research agenda

The National Institute of Allergy and Infectious Diseases (NIAID) today released the NIAID Counter-Bioterrorism Research Agenda for CDC Category A Agents, a document describing the Institute's accelerated research plan for the most threatening agents of bioterrorism. The agenda outlines the research NIAID will undertake to help protect civilian populations from diseases such as smallpox, anthrax and plague should they be unleashed intentionally by those who wish to do harm.

The comprehensive plan includes short-, intermediate- and long-term research goals and describes specifically how bioterrorism countermeasures will be developed for each microbe. The document also contains a copy of the Strategic Plan for Counter-Bioterrorism Research of the NIAID, which provides a general overview of the Institute's broad plans for attacking the full range of potential bioterrorism pathogens.

"Research is a vital element of bioterrorism defense," says HHS Secretary Tommy G. Thompson. "The NIAID Counter-Bioterrorism Research Agenda describes the highest priorities of an accelerated program to expand research on bioterrorism agents and to quickly develop new diagnostics, drugs and vaccines to protect the public."

The Research Agenda was developed by NIAID scientists and reviewed by an outside panel of experts from academia, industry and government in early February. The plan focuses on the Category A diseases as described by the Centers for Disease Control and Prevention (CDC): anthrax, smallpox, plague, tularemia, viral hemorrhagic fevers and botulism. Those diseases cause high death rates or serious illness, are relatively easy to spread, could cause public panic or require special steps for public health preparedness. NIAID plans to develop research plans for CDC Category B and C agents in the near future.

As the National Institutes of Health's lead institute on immunology and infectious diseases research, NIAID has made many key contribu
'"/>

Contact: Sam Perdue
sp189u@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
14-Mar-2002


Page: 1 2 3 4

Related biology news :

1. TIGR and NIAID sign $65 million microbial sequencing contract
2. NIAID takes next genome step
3. NIAID awards grant to rapidly sequence the malaria mosquito genome
4. NIAID launches major step in trial of experimental shingles vaccine
5. NIAID-Supported Scientists Discover Origin Of HIV-1
6. NIAID Scientists Discover HIV Disease-Slowing Mutation
7. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
8. Pacific Northwest team unveils largest virus proteome to date
9. Pacific Northwest National Lab unveils most complete human blood-plasma proteome map to date
10. Department of Energys Office of Science unveils 20-year vision for the future of basic research
11. Ancient DNA analysis unveils mystery of historys most horribly deformed man -- The Elephant Man

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... ACEA Biosciences, ... The company has just introduced the xCELLigence RTCA S16, which the ideal ... monitored via an external computer, the S16can be placed in any standard CO2 tissue ...
(Date:7/30/2018)... ... 30, 2018 , ... TC Slade, an evidence-based healer, today ... healing treated Vitamin D3 on the strength and health of bones. , ... in ALP, a bone-specific enzyme ,     Over 240% increase in collagen levels ...
(Date:7/27/2018)... (PRWEB) , ... July 27, ... ... and Renewable Products Advocacy Group (BRAG®) and representatives of the Biotechnology Innovation ... the two groups’ recently-issued white paper, “Proposal for a Toxic Substances Control ...
Breaking Biology News(10 mins):
(Date:8/9/2018)... ... August 09, 2018 , ... Simpson Gumpertz & Heger ... with building owners and managers for a full-day discussion on health care and ... to Boston for the first time on Thursday, 13 September 2018, at Harvard ...
(Date:8/7/2018)... BURLINGTON, Mass. (PRWEB) , ... August 06, 2018 , ... ... Orivet , a leader in pet genetic testing, today announced the launch of a ... study is an extension of another ongoing general study of pregnant dogs sponsored by ...
(Date:7/31/2018)... ... July 31, 2018 , ... ... that covers methods for extracting and using adipose tissue-derived stem cells to treat ... humans. While this patent covers Canada specifically, VetStem has been issued similar ...
(Date:7/31/2018)... ... 2018 , ... Mahoney Environmental , a leading recycler ... website. The new website has been designed with improved functionality and navigation, while ... to build a website created for the customer. The newly redesigned site includes ...
Breaking Biology Technology:
Cached News: